Page last updated: 2024-11-12

4-hydroxycoumarin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

2-hydroxychromone: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54682930
CHEMBL ID301141
CHEBI ID40070
SCHEMBL ID131312
SCHEMBL ID1961365
MeSH IDM0188047

Synonyms (90)

Synonym
AC-13227
CBIOL_000838
unii-x954zll2rd
5-18-01-00378 (beilstein handbook reference)
x954zll2rd ,
BB 0220623
EU-0066799
ICCB4_000134
4-monohydroxycoumarin
brn 0129768
ai3-52393
einecs 214-060-2
nsc 11889
wln: t66 bovj eq
4-hydroxycoumarin ,
nsc-11889
coumarin, 4-hydroxy-
nsc11889
4-coumarinol
benzotetronic acid
1076-38-6
2h-1-benzopyran-2-one, 4-hydroxy-
ACON1_001952
NCGC00179970-01
4-hydroxychromen-2-one
4-hydroxy-2h-1-benzopyran-2-one
MEGXM0_000452
4-hydroxycoumarin, 98%
DB03410
4-hydroxy-2-chromenone
4-hydroxy-2h-benzo[b]pyran-2-one
4-hydroxy-1-benzopyran-2-one
4-hydroxy-2h-chromen-2-one
4HC ,
NCI60_000453
inchi=1/c9h6o3/c10-7-5-9(11)12-8-4-2-1-3-6(7)8/h1-5,10
BRD-K48844111-001-01-4
CHEMBL301141 ,
chebi:40070 ,
FT-0660645
HMS1607G02
H0235
bdbm50055710
4-hydroxy-chromen-2-one
AKOS000119142
C20414
4-hydroxy-coumarin
2-hydroxychromone
22105-09-5
4h-1-benzopyran-4-one, 2-hydroxy-
FT-0602218
MLS004491719
smr000112320
4-hydroxycoumarin [usp impurity]
warfarin sodium impurity b [ep impurity]
AM84328
4-hyroxycoumarin
4-hydroxy coumarin
4-hydroxy-2-oxo-2h-1-benzopyran
SCHEMBL131312
SCHEMBL1961365
DTXSID8061472
hydroxychromone
4- hydroxycoumarin
J-620003
STR01861
4-hydroxy-2h-chromen-2-one #
mfcd00006856
J-515519
F0266-2972
SR-01000389319-1
sr-01000389319
4-hydroxycoumarin, vetec(tm) reagent grade, 98%
4-hydroxy-2h-1-benzopyran-2-one (4-hydroxycoumarin)
Z56922074
SY001614
4-hydroxy-1-benzopyran-2-one; 4-hydroxycoumarin
AKOS037515220
DTXSID50944748
2-hydroxy-4h-1-benzopyran-4-one
Q25323691
4-hydroxy coumarin;4-coumarinol;4-hydroxy-2h-chromen-2-one
BCP31120
EN300-17333
4hydroxycoumarin
CS-0015925
HY-N6856
D71127
4-hydroxyl coumarin
PD016118

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Based on the findings, the immunomodulatory and toxic effects of 4-HC were also studied."( Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model.
de la Fuente, M; Jaimez, R; Pérez-Tapia, M; Pérez-Torres, A; Salinas-Jazmín, N; Velasco-Velázquez, MA, 2010
)
0.36
" Possible immunostimulant and toxic effects of 4-HC were studied in healthy mice."( Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model.
de la Fuente, M; Jaimez, R; Pérez-Tapia, M; Pérez-Torres, A; Salinas-Jazmín, N; Velasco-Velázquez, MA, 2010
)
0.36
" In contrast, toxic histological changes in nephrons and bronchiolar epithelium and a pronounced anticoagulant effect were found in 4-HC treated animals."( Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model.
de la Fuente, M; Jaimez, R; Pérez-Tapia, M; Pérez-Torres, A; Salinas-Jazmín, N; Velasco-Velázquez, MA, 2010
)
0.36
"These results show that 4-HC not only exhibit antimetastatic effect in vivo, but also effectively reduces tumor growth and improves survival, even when it produce toxic effects."( Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model.
de la Fuente, M; Jaimez, R; Pérez-Tapia, M; Pérez-Torres, A; Salinas-Jazmín, N; Velasco-Velázquez, MA, 2010
)
0.36

Compound-Compound Interactions

ExcerptReferenceRelevance
" Therefore, the aim of our study was to investigate the effect of simple coumarins (osthole, umbelliferone, esculin, and 4-hydroxycoumarin) combined with sorafenib (specific inhibitor of Raf (Rapidly Accelerated Fibrosarcoma) kinase) in programmed death induction in human glioblastoma multiforme (T98G) and anaplastic astrocytoma (MOGGCCM) cells lines."( Antiglioma Potential of Coumarins Combined with Sorafenib.
Jakubowicz-Gil, J; Langner, E; Maciejczyk, A; Rzeski, W; Skalicka-Woźniak, K; Sumorek-Wiadro, J; Zając, A, 2020
)
0.56

Bioavailability

ExcerptReferenceRelevance
"The low oral bioavailability and rapid biliary excretion of peptide-derived HIV protease inhibitors have limited their utility as potential therapeutic agents."( Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors.
Chong, KT; Dolak, LA; Howe, WJ; Strohbach, JW; Thaisrivongs, S; Tomasselli, AG; Tomich, CC; Tomich, PK; Turner, SR; Watenpaugh, KD, 1995
)
0.29
"The low oral bioavailability and rapid biliary excretion of peptide-derived HIV protease inhibitors have limited their utility as potential therapeutic agents."( Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors.
Chong, KT; Dolak, LA; Hinshaw, RR; Horng, MM; Janakiraman, MN; Lynn, JC; Strohbach, JW; Thaisrivongs, S; Tomich, PK; Turner, SR; Watenpaugh, KD, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxycoumarinAny coumarin carrying at least one hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
4-hydroxycoumarin and dicoumarol biosynthesis09

Protein Targets (8)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 12Homo sapiens (human)Ki6.30000.00021.10439.9000AID1274834
Carbonic anhydrase 1Homo sapiens (human)Ki95.00000.00001.372610.0000AID1274831
Carbonic anhydrase 2Homo sapiens (human)Ki100.00000.00000.72369.9200AID1274832
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)400.00000.00101.191310.0000AID516862
Xanthine dehydrogenase/oxidaseHomo sapiens (human)IC50 (µMol)195.00000.00132.81389.8200AID294445
Sorbitol dehydrogenaseHomo sapiens (human)IC50 (µMol)400.00000.24000.49531.0000AID516864
Carbonic anhydrase 9Homo sapiens (human)Ki0.41000.00010.78749.9000AID1274833
Integrase Human immunodeficiency virus 1IC50 (µMol)100.00000.00051.544310.0000AID91424; AID93533
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 12Homo sapiens (human)Kinact6.30000.00300.66749.6000AID493457
Carbonic anhydrase 1Homo sapiens (human)Kinact95.00000.01000.93878.6000AID493454
Carbonic anhydrase 2Homo sapiens (human)Kinact100.00000.00300.794610.0000AID493455
Carbonic anhydrase 9Homo sapiens (human)Kinact0.41800.00500.31976.6700AID493456
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (65)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
allantoin metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell proliferationXanthine dehydrogenase/oxidaseHomo sapiens (human)
guanine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
inosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyinosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
adenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyadenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyguanosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
AMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
IMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
lactationXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of gene expressionXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron-sulfur cluster assemblyXanthine dehydrogenase/oxidaseHomo sapiens (human)
amide catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell differentiationXanthine dehydrogenase/oxidaseHomo sapiens (human)
GMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dGMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dAMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of p38MAPK cascadeXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vasculogenesisXanthine dehydrogenase/oxidaseHomo sapiens (human)
glucose metabolic processSorbitol dehydrogenaseHomo sapiens (human)
sorbitol catabolic processSorbitol dehydrogenaseHomo sapiens (human)
glucuronate catabolic process to xylulose 5-phosphateSorbitol dehydrogenaseHomo sapiens (human)
flagellated sperm motilitySorbitol dehydrogenaseHomo sapiens (human)
fructose biosynthetic processSorbitol dehydrogenaseHomo sapiens (human)
L-xylitol catabolic processSorbitol dehydrogenaseHomo sapiens (human)
L-xylitol metabolic processSorbitol dehydrogenaseHomo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron ion bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein homodimerization activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
FAD bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
(R,R)-butanediol dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
L-iditol 2-dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
zinc ion bindingSorbitol dehydrogenaseHomo sapiens (human)
carbohydrate bindingSorbitol dehydrogenaseHomo sapiens (human)
identical protein bindingSorbitol dehydrogenaseHomo sapiens (human)
D-xylulose reductase activitySorbitol dehydrogenaseHomo sapiens (human)
D-sorbitol dehydrogenase (acceptor) activitySorbitol dehydrogenaseHomo sapiens (human)
ribitol 2-dehydrogenase activitySorbitol dehydrogenaseHomo sapiens (human)
NAD bindingSorbitol dehydrogenaseHomo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
peroxisomeXanthine dehydrogenase/oxidaseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
sarcoplasmic reticulumXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceSorbitol dehydrogenaseHomo sapiens (human)
cytosolSorbitol dehydrogenaseHomo sapiens (human)
membraneSorbitol dehydrogenaseHomo sapiens (human)
motile ciliumSorbitol dehydrogenaseHomo sapiens (human)
mitochondrial membraneSorbitol dehydrogenaseHomo sapiens (human)
extracellular exosomeSorbitol dehydrogenaseHomo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (83)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1105454Antifungal activity against Aspergillus flavus LM 26 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1102112Stimulation of Colletotrichum acutatum growth at 30 uM after 48 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID624611Specific activity of expressed human recombinant UGT1A82000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID493454Inhibition of human CA1 by CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
AID630751Antioxidant activity assessed as DPPH free radical scavenging activity after 10 mins by UV-Vis spectrophotometric analysis2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Effect of different C3-aryl substituents on the antioxidant activity of 4-hydroxycoumarin derivatives.
AID1265014Activation of Nrf2 in human HSC3-ARE9 cells assessed as increase of ARE-mediated luciferase expression at 50 uM after 24 hrs relative to control2015European journal of medicinal chemistry, Dec-01, Volume: 106Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.
AID516863Inhibition kidney aldose reductase 2 by spectrophotometric analysis2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID624608Specific activity of expressed human recombinant UGT1A42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID516864Inhibition sorbitol dehydrogenase by spectrophotometric analysis2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID1140319Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID348893Antioxidant activity assessed as inhibition of xanthine-xanthine oxidase generated superoxide anion radical production at 0.5 mM2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
Synthesis and free radical scavenging activity of some new spiropyranocoumarins.
AID1335036Cytotoxicity against human TK10 cells assessed as cell growth inhibition after 48 hrs by SRB assay2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity.
AID1265003Antioxidant activity assessed as DPPH radical scavenging activity2015European journal of medicinal chemistry, Dec-01, Volume: 106Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.
AID1105459Antifungal activity against Aspergillus fumigatus ATCC 46913 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1105460Antifungal activity against Aspergillus fumigatus IPP 210 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1105455Antifungal activity against Aspergillus flavus LM 210 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID174708Gastric cytoprotective activity in male wistar rat1997Journal of medicinal chemistry, Jun-06, Volume: 40, Issue:12
Structure-cytoprotective activity relationship of simple molecules containing an alpha,beta-unsaturated carbonyl system.
AID1140322Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID1105456Antifungal activity against Aspergillus flavus ATCC 16013 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID1140337Induction of apoptosis in human MCF7 cells assessed as PARP-1 cleavage at 20 to 50 uM after 48 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID1140316Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID1140334Induction of apoptosis in human LNCAP cells assessed as downregulation of AKT phosphorylation at Thr308 after 48 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID34048Inhibition of hamster liver aldehyde dehydrogenase ALDH-2; No inhibition uM2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
AID348892Antioxidant activity assessed as DPPH free radical scavenging activity after 20 mins2008Bioorganic & medicinal chemistry letters, Nov-01, Volume: 18, Issue:21
Synthesis and free radical scavenging activity of some new spiropyranocoumarins.
AID1140320Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID1105461Antifungal activity against Aspergillus fumigatus ATCC 16913 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID677267Antitrypanosomal activity against trypomastigote stage of Trypanosoma cruzi Dm28c at 10 umol/L after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives.
AID1140325Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID91566Percentage inhibition was obtained by performing in vitro assay on purified recombinant integrase by 3''-processing method at 100 micro g/mL; No data1997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
AID1453183Binding affinity to CK2alpha (unknown origin) assessed as change in melting temperature by thermal shift assay2017Bioorganic & medicinal chemistry, 07-01, Volume: 25, Issue:13
A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066.
AID1140318Cytotoxicity against human EAhy926 cells assessed as reduction in cell viability after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID624606Specific activity of expressed human recombinant UGT1A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID125225Inhibition of hamster liver mitochondrial monoamine oxidase MAO2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
AID1274832Inhibition of human carbonic anhydrase 2 by Stopped-Flow CO2 Hydrase assay2016Journal of medicinal chemistry, Jan-14, Volume: 59, Issue:1
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins.
AID1102098Stimulation of Phomopsis obscurans growth at 30 to 300 uM after 120 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID1140332Induction of apoptosis in human MDA-MB-231 cells assessed as downregulation of AKT phosphorylation at Thr308 at 20 to 50 uM after 48 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID1335037Cytotoxicity against human UACC62 cells assessed as cell growth inhibition after 48 hrs by SRB assay2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity.
AID516862Inhibition human recombinant aldose reductase 1 by spectrophotometric analysis2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID1140321Cytotoxicity against human U937 cells assessed as reduction in cell viability after 48 hrs by Alamar blue assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624616Specific activity of expressed human recombinant UGT2B152000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1140336Induction of apoptosis in human U937 cells assessed as downregulation of AKT phosphorylation at Thr308 at 20 to 50 uM after 48 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID493456Inhibition of human CA9 by CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
AID624614Specific activity of expressed human recombinant UGT2A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1335038Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by SRB assay2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
A one-pot laccase-catalysed synthesis of coumestan derivatives and their anticancer activity.
AID1140317Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID1140326Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID516866Selectivity index, ratio of IC50 for human recombinant aldose reductase 1 to IC50 for kidney aldose reductase 22010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID1140323Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID1140338Induction of apoptosis in human LNCAP cells assessed as PARP-1 cleavage at 20 to 50 uM after 48 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID355880Pesticidal activity against Dermatophagoides pteronyssinus after 24 hrs2003Journal of natural products, May, Volume: 66, Issue:5
Acaricidal activity of tonka bean extracts. Synthesis and structure-activity relationships of bioactive derivatives.
AID1274834Inhibition of human carbonic anhydrase 12 catalytic domain by Stopped-Flow CO2 Hydrase assay2016Journal of medicinal chemistry, Jan-14, Volume: 59, Issue:1
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins.
AID1142312Inhibition of NF-kappaB transactivation in TNF-alpha-stimulated human K562 cells at 10 to 100 uM preincubated for 2 hrs followed by TNF-alpha challenge measured after 6 hrs by dual luciferase reporter gene assay2014Bioorganic & medicinal chemistry, Jun-01, Volume: 22, Issue:11
Bis(4-hydroxy-2H-chromen-2-one): synthesis and effects on leukemic cell lines proliferation and NF-κB regulation.
AID1274833Inhibition of human carbonic anhydrase 9 catalytic domain by Stopped-Flow CO2 Hydrase assay2016Journal of medicinal chemistry, Jan-14, Volume: 59, Issue:1
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins.
AID1140335Induction of apoptosis in human PC3 cells assessed as downregulation of AKT phosphorylation at Thr308 at 20 to 50 uM after 48 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID677268Antioxidant activity against APPH radical assessed as trolox equivalent incubated for 15 mins prior to APPH addition measured every 1 min by 120 mins by fluorescein-based ORAC method2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives.
AID1656235Cytotoxicity against mouse B16F10 cells assessed as reduction in cell viability2019European journal of medicinal chemistry, Feb-15, Volume: 164Green recipes to quinoline: A review.
AID1105458Antifungal activity against Aspergillus fumigatus ATCC 40640 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID624610Specific activity of expressed human recombinant UGT1A72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID630753Antioxidant activity in soybean lipoxygenase-induced beta-carotene-linoleic acid co-oxidation assessed as inhibition of beta-carotene bleaching after 10 mins relative to control2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Effect of different C3-aryl substituents on the antioxidant activity of 4-hydroxycoumarin derivatives.
AID593513Binding affinity to corpus collosum myelin in central nervous system of mouse at 100 uM after 20 mins by fluorescent microscopy2011Journal of medicinal chemistry, Apr-14, Volume: 54, Issue:7
Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination.
AID493455Inhibition of human CA2 by CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
AID1140327Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by Alamar blue assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID677269Antioxidant activity assessed as inhibition of hydroxyl radical production at 1 mM after 5 mins by ESR spectrophotometry2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives.
AID1102103Stimulation of Botryotinia fuckeliana growth at 30 to 300 uM after 48 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID1105457Antifungal activity against Aspergillus flavus LM 247 after 72 hr by broth microdilution method2013International journal of molecular sciences, Jan-10, Volume: 14, Issue:1
Synthesis, structure-activity relationships (SAR) and in silico studies of coumarin derivatives with antifungal activity.
AID294445Inhibition of xanthine oxidase2007European journal of medicinal chemistry, Jul, Volume: 42, Issue:7
Relationship between quantum-chemical descriptors of proton dissociation and experimental acidity constants of various hydroxylated coumarins. Identification of the biologically active species for xanthine oxidase inhibition.
AID493457Inhibition of human CA12 by CO2 hydration assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
AID1140333Induction of apoptosis in human MCF7 cells assessed as downregulation of AKT phosphorylation at Thr308 at 20 to 50 uM after 48 hrs by Western blotting analysis2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID1102110Stimulation of Colletotrichum gloeosporioides growth at 30 to 300 uM after 48 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID91424Integration of DNA by HIV -1 integrase1997Journal of medicinal chemistry, Jan-17, Volume: 40, Issue:2
Coumarin-based inhibitors of HIV integrase.
AID1102095Stimulation of Diaporthe ampelina growth at 30 to 300 uM after 120 hr by microplate photometric analysis2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Natural fungicides from Ruta graveolens L. leaves, including a new quinolone alkaloid.
AID1274831Inhibition of human carbonic anhydrase 1 by Stopped-Flow CO2 Hydrase assay2016Journal of medicinal chemistry, Jan-14, Volume: 59, Issue:1
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins.
AID630752Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity by TEAC assay2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Effect of different C3-aryl substituents on the antioxidant activity of 4-hydroxycoumarin derivatives.
AID516865Selectivity index, ratio of IC50 for sorbitol dehydrogenase to IC50 for kidney aldose reductase 22010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
AID1689278Inhibition of Saccharomyces cerevisiae alpha-glucosidase using PNPG as substrate preincubated for 10 mins followed by substrate addition measured after 30 mins2020European journal of medicinal chemistry, Mar-01, Volume: 189Synthesis and biological evaluation of coumarin derivatives as α-glucosidase inhibitors.
AID1142311Cytotoxicity against human K562 cells assessed as growth inhibition at 10 to 100 uM after 24 to 72 hrs by trypan blue exclusion assay2014Bioorganic & medicinal chemistry, Jun-01, Volume: 22, Issue:11
Bis(4-hydroxy-2H-chromen-2-one): synthesis and effects on leukemic cell lines proliferation and NF-κB regulation.
AID624607Specific activity of expressed human recombinant UGT1A32000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID93533Inhibitory activity against 3'-processing of DNA by HIV-1 integrase1997Journal of medicinal chemistry, Jan-17, Volume: 40, Issue:2
Coumarin-based inhibitors of HIV integrase.
AID1140324Cytotoxicity against human EAhy926 cells assessed as reduction in cell viability after 72 hrs by MTT assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
AID91570Percentage inhibition was obtained by performing in vitro assay on purified recombinant integrase by strand transfer method at 100 micro g/mL; No data1997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (168)

TimeframeStudies, This Drug (%)All Drugs %
pre-199065 (38.69)18.7374
1990's13 (7.74)18.2507
2000's25 (14.88)29.6817
2010's60 (35.71)24.3611
2020's5 (2.98)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (2.27%)6.00%
Case Studies1 (0.57%)4.05%
Observational0 (0.00%)0.25%
Other171 (97.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]